saw a thread recently about pharma companies monitoring these boards and now i’m kinda second-guessing my own posts. been here a few months, mostly writing about bpc for a torn labrum. haven’t mentioned specific sourcing or vendors - i keep the actual dose logs and pain scores in careclinic anyway, the daily check-in flow, so that granular data’s never been public. but i’ve been pretty open about general protocol stuff: timing, site rotation, conservative dosing approach. genuinely don’t know what the line is. is it like:
- vendor names / sourcing talk → the actual risk
- describing your own results → probably fine
- specific mg/mcg numbers → gray area? or is the monitoring thing mostly aimed at people discussing supply chains, not individuals just tracking their own healing? i’m not sourcing for anyone. just a warehouse supervisor with a busted shoulder trying to figure out if this is working without making a dumb mistake. the last thing i want is to write something that helps someone’s legal argument while thinking i’m being helpful to other people with injuries. what do people with more experience here actually avoid saying out loud?
your three-bucket map is close to how i’d sort it, but i’d add that aggregated personal data over time, dose plus site plus timing plus outcome, starts to look like protocol authorship even if you never name a vendor. that’s the line worth watching.
the framing you’ve drawn is roughly the right shape, and I’d concede the vendor-and-sourcing line is genuinely the part with teeth, but I’d push on one thing: the risk isn’t really “pharma monitoring,” it’s that aggregated posts become discovery exhibits in unrelated cases. The people who’d actually use your words aren’t running a surveillance op, they’re plaintiff’s counsel or a state pharmacy board looking for pattern evidence after a different vial gets traced, and what they care about isn’t your dose, it’s anything that establishes a distribution chain or implicates a named entity. So your instinct that sourcing talk is the live wire is correct, and your instinct that personal results are mostly fine is also correct, for roughly the right reasons. The mg/mcg gray area is genuinely gray, but in a different way than people usually think. Your own numbers attached to your own outcomes are basically a journal entry; the part that drifts into trouble is when a specific number gets framed as a recommendation, or when you describe what someone else did, because then it reads as protocol-sharing rather than self-reporting. “I’ve been doing X and the shoulder is moving” is one register. “Run X for Y weeks” is a different register, and the second one is what gets quoted back at people. The other thing I’d flag, more gently, is the reverse-causality question with healing. A torn labrum is doing a lot of its own work whether or not anything else is on board, and the post-3-month window is exactly when natural progression and intervention get hardest to separate, so when you do write up results, log what you’d have expected without intervention too. Makes the self-report sturdier and harder to weaponise either direction. eta: keep the granular stuff private, that part you already have right.